Bill > S848

This bill requires all covered entities participating in the 340B drug pricing program (a federal program that allows certain healthcare organizations to purchase outpatient drugs at discounted rates) to submit an annual report to the Center for Health Information and Analysis starting April 1, 2026. The report must include detailed financial information such as drug acquisition costs, insurance payments, prescription volumes, and operational expenses broken down by insurance type. Entities must also disclose specific costs related to implementing 340B program discounts, sliding fee scales for low-income patients, and charity care. Additionally, the report must provide comprehensive details about contract pharmacies, including the number of in-state and out-of-state pharmacies, total prescriptions filled, remuneration paid to these pharmacies, and year-over-year changes in pharmacy compensation. An authorized officer of the covered entity must certify the report's accuracy, and the Center for Health Information and Analysis will publicly post all submitted reports on an accessible website. The primary goal of this legislation is to increase transparency and accountability in how healthcare organizations utilize the 340B drug pricing program, with a particular focus on ensuring benefits for vulnerable patient populations.

Health and Social Services

https://malegislature.gov/Bills/194/S848